Setegis
Setegis contains the active ingredient Terazosin, which belongs to a class of medications known as alpha-blockers. It is primarily used to treat high blood pressure (hypertension), helping to relax blood vessels so that blood can flow more easily. Additionally, Setegis can be prescribed for the treatment of benign prostatic hyperplasia (BPH), a condition characterized by an enlarged prostate. By improving urine flow and reducing symptoms of BPH, it enhances the quality of life for affected individuals. Setegis tablets are available in various dosages to cater to different patient needs and should be taken consistently for optimal results. Always follow the prescribed dosage to ensure the best therapeutic outcome.Active substance:
TerazosinPharmachologic effect:
Setegis is an alpha-1 adrenergic receptor blocker that helps to relax the muscles in the prostate and bladder neck, making it easier to urinate. It is primarily used to treat symptoms of an enlarged prostate (benign prostatic hyperplasia) and hypertension.Indications:
- Benign prostatic hyperplasia (BPH)
- Hypertension
Contraindications:
- Hypersensitivity to terazosin or any component of the formulation
- History of orthostatic hypotension
Side effects:
In order of decreasing probability: Dizziness, Headache, Nasal congestion, Asthenia, Palpitations, Nausea, Peripheral edema, Somnolence
Dosing and Administration:
For benign prostatic hyperplasia, the initial dose is 1 mg at bedtime, which may be gradually increased to a maintenance dose of 5 to 10 mg once daily. For hypertension, the initial dose is 1 mg at bedtime, with a maintenance dose ranging from 1 to 5 mg once daily, depending on the patient's response.
Storage:
Store at a temperature not exceeding 25°C (77°F).
Setegis
in Cyrillic : Сетегис
SUBSTANCE
Terazosin
DOSAGE FORM
tablets
MANUFACTURER
In Stock
available pack options :
| 2mg x 30 tablets | $55.50 |
| 5mg x 30 tablets | $87.00 |
